Chemed Co. (NYSE:CHE) Shares Acquired by MetLife Investment Management LLC

MetLife Investment Management LLC lifted its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 8.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,511 shares of the company's stock after acquiring an additional 666 shares during the quarter. MetLife Investment Management LLC owned 0.06% of Chemed worth $4,509,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of CHE. Franklin Resources Inc. boosted its stake in shares of Chemed by 21.3% during the 3rd quarter. Franklin Resources Inc. now owns 8,800 shares of the company's stock worth $5,282,000 after acquiring an additional 1,544 shares in the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of Chemed by 11.4% during the 4th quarter. Central Pacific Bank Trust Division now owns 880 shares of the company's stock worth $466,000 after acquiring an additional 90 shares in the last quarter. Nordea Investment Management AB boosted its stake in shares of Chemed by 4.9% during the 4th quarter. Nordea Investment Management AB now owns 13,639 shares of the company's stock worth $7,242,000 after acquiring an additional 635 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of Chemed by 18.4% during the 4th quarter. Harbor Capital Advisors Inc. now owns 3,188 shares of the company's stock worth $1,689,000 after acquiring an additional 496 shares in the last quarter. Finally, Sugarloaf Wealth Management LLC boosted its stake in shares of Chemed by 21.9% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,150 shares of the company's stock worth $3,788,000 after acquiring an additional 1,285 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Royal Bank of Canada lifted their price objective on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

Chemed Stock Down 0.5 %

Shares of Chemed stock traded down $3.06 during trading on Wednesday, hitting $571.90. 22,060 shares of the company were exchanged, compared to its average volume of 98,745. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $623.61. The stock has a market capitalization of $8.36 billion, a price-to-earnings ratio of 28.91, a P/E/G ratio of 2.15 and a beta of 0.49. The firm has a 50 day moving average price of $588.34 and a 200 day moving average price of $566.62.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company's quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.20 EPS. Analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.35%. Chemed's dividend payout ratio (DPR) is presently 9.74%.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 3.29% of the stock is currently owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.